| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 05/10/2013 | CA2851095A1 A medicament for treating anterior eye disease comprising rebamipide and a tear-retaining agent |
| 05/09/2013 | US20130116312 Plasmalogen compounds, pharmaceutical compositions containing the same and methods for treating diseases of the aging |
| 05/09/2013 | US20130116279 Bicyclic heteroaryl inhibitors of pde4 |
| 05/09/2013 | US20130116268 Use of modified pyrimidine compounds to promote stem cell migration and proliferation |
| 05/09/2013 | US20130116255 Combination of brimonidine and timolol for topical ophthalmic use |
| 05/09/2013 | US20130116237 [6,6] and [6,7]-bicyclic gpr119 g protein-coupled receptor agonists |
| 05/09/2013 | US20130116219 Antimicrobial carboline compounds |
| 05/09/2013 | US20130115224 METHODS OF TREATING DISORDERS USING HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 05/08/2013 | EP2589588A1 Use of bipolar trans carotenoids as a pretreatment and in the treatment of peripheral vascular disease |
| 05/08/2013 | EP2589386A1 Method for inhibiting myopia and use of adenylate cyclase inhibitor as drug for inhibiting myopia |
| 05/08/2013 | EP2588138A1 Treatment of vascularized pigment epithelial detachment with anti-vegf therapy |
| 05/08/2013 | EP2588128A1 Lactoferrin sequences, compositions and methods of corneal wound treatment |
| 05/08/2013 | EP2588098A1 Compounds for the treatment of posterior segment disorders and diseases |
| 05/08/2013 | EP2588096A1 Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease |
| 05/08/2013 | EP2588049A2 Ophthalmic devices containing chemokine antagonists |
| 05/08/2013 | CN103096929A Agent for treatment of dry eye characterized by combining P2Y2 receptor agonist with hyaluronic acid or salt thereof, method for treating dry eye, and use of the P2Y2 receptor agonist and hyaluronic acid or salt thereof |
| 05/08/2013 | CN103087192A Anti-KDR antibodies and methods of use |
| 05/08/2013 | CN103087153A New neovessel inhibition small peptides and applications thereof |
| 05/08/2013 | CN103087078A Thienopyridine and furopyridine kinase inhibitors |
| 05/08/2013 | CN103087066A Haloaryl Substituted Aminopurines, Compositions Thereof, And Methods Of Treatment Therewith |
| 05/08/2013 | CN103087024A Flavone alkylamine compounds as well as preparation method and application thereof |
| 05/08/2013 | CN103086943A Indoles derivative functioning as CRTH2 receptor antagonist |
| 05/08/2013 | CN103083669A Method for treatment of inflammatory disease and disorder |
| 05/08/2013 | CN103083634A Radix bupleuri and rhizoma coptidis tablets |
| 05/08/2013 | CN103083569A Chinese medicament for treating conjunctivitis and preparation method thereof |
| 05/08/2013 | CN103083565A Preparation method for Behcet disease treatment traditional Chinese medicine preparation |
| 05/08/2013 | CN103083546A Method for processing condensed pill for regaining sight |
| 05/08/2013 | CN103083370A Novel application of total flavones of hippophae rhamnoides |
| 05/08/2013 | CN103083362A Multipurpose functional water and preparation method thereof |
| 05/08/2013 | CN103083354A Compound sodium chloride eye drops |
| 05/08/2013 | CN103083341A Use of anthracycline antibiotics in preparation of medicines for treating age-related macular degeneration |
| 05/08/2013 | CN103083326A Ulipristal acetate medicine composition |
| 05/08/2013 | CN103083270A Xanthophyll chewable tablet |
| 05/08/2013 | CN103083263A Trovafloxacin ear drop pill for dogs and cats |
| 05/08/2013 | CN103083224A Method for preparing dexamethasone slow-release medicine carrier |
| 05/08/2013 | CN102600050B Eye-protecting health care patch with self-heating steam and nutrition |
| 05/08/2013 | CN102429885B DC (Directly compressible)-xylitol and preparation method thereof |
| 05/08/2013 | CN102309607B Chinese medicine decoction for treating diabetic retinopathy and preparation method thereof |
| 05/08/2013 | CN102286101B Fab (fragment of antigen binding) fragment Vasculizumab of anti-VEGF (vascular endothelial growth factor) monoclonal antibody and application thereof |
| 05/08/2013 | CN102242070B Method for artificially culturing paecilomyces cicadae and application of culturing product thereof |
| 05/08/2013 | CN102060842B 3-(substituted xylylenimine-2-yl)-2,6-piperidine diketone polymorph and medical composition |
| 05/08/2013 | CN101687795B Neurite formation promoter |
| 05/08/2013 | CN101560546B Application of Phosphatidylinositol4-kinase type II alpha PI4KIIalpha |
| 05/08/2013 | CN101400703B Domain antibody construct |
| 05/07/2013 | US8435981 2-(heterocyclylbenzyl)pyridazinone derivatives |
| 05/07/2013 | US8435503 Ophthalmic and ophthalmological use of a complex nutritive base in aqueous medium |
| 05/02/2013 | WO2013063269A2 Compounds and methods of treating ocular disorders |
| 05/02/2013 | WO2013062947A1 Amide derivatives of n-urea substituted amino acids as formyl peptide receptor like-1 (fprl-1) receptor modulators |
| 05/02/2013 | WO2013062843A1 Pyridine- sulfoximines as tyrosine kinase inhibitors |
| 05/02/2013 | WO2013061977A1 Heterocycle derivative having pgd2 receptor antagonist activity |
| 05/02/2013 | WO2013061269A1 Combinations of loteprednol and olopatadine for the treatment of ocular allergies |
| 05/02/2013 | WO2013060908A1 Use of a melatonin analogue for the reduction of intraocular pressure |
| 05/02/2013 | WO2013060303A1 Polypeptides inhibiting neovascularization and uses thereof |
| 05/02/2013 | WO2013060020A1 Novel small peptide capable of inhibiting new vessels and application thereof |
| 05/02/2013 | WO2012163827A3 Ophthalmic preparation comprising a pgf2alpha analogue |
| 05/02/2013 | US20130109614 Antagonists for diseases induced by cells with high-affinity elr-cxc chemokine receptor proteins |
| 05/02/2013 | CA2853648A1 Amide derivatives of n-urea substituted amino acids as formyl peptide receptor like-1 (fprl-1) receptor modulators |
| 05/02/2013 | CA2853379A1 Vectors encoding rod-derived cone viability factor |
| 05/02/2013 | CA2853062A1 Pyridine- sulfoximines as tyrosine kinase inhibitors |
| 05/02/2013 | CA2852627A1 Heterocyclic derivative having pgd2 receptor antagonist activity |
| 05/01/2013 | EP2586795A2 Use of anti-amyloid beta antibody in ocular diseases |
| 05/01/2013 | EP2586426A1 Carboxyvinyl polymer-containing nanoparticle suspensions |
| 05/01/2013 | EP2585071A1 Pharmaceutical composition for use in the treatment of glaucoma |
| 05/01/2013 | EP2585054A1 Derivatives of cycloalkyl- and cycloalkenyl-1,2-dicarboxylic acid compounds having formyl peptide receptor like-1 (fprl-1) agonist or antagonist activity |
| 05/01/2013 | CN1564682B Compositions for potentiating glutatthione |
| 05/01/2013 | CN103079595A Aqueous composition for ophthalmic administration |
| 05/01/2013 | CN103079550A N-acetyl-DL-leucine, neuroprotective and retinoprotective medicament |
| 05/01/2013 | CN103073620A KDR peptides and vaccines comprising the same |
| 05/01/2013 | CN103073440A Diphenylvinyloxy alkylamine compound and preparation method as well as application thereof |
| 05/01/2013 | CN103071089A Traditional Chinese medicine powder for treating epidemic keratoconjunctivitis |
| 05/01/2013 | CN103071074A Chinese herbal medicine oral liquid for refreshing, recovering from fatigue, boosting brain and improving eyesight |
| 05/01/2013 | CN103071052A Medicine for treating evaporative dry eyes |
| 05/01/2013 | CN103071046A Medicine paste for treating high myopia macular hemorrhage |
| 05/01/2013 | CN103071044A Traditional Chinese medicine composition for preventing and / or treating sicca syndrome and preparation method thereof |
| 05/01/2013 | CN103071012A Medicine for curing chronic simple glaucoma |
| 05/01/2013 | CN103070992A Medicine for treating high myopia macular hemorrhages |
| 05/01/2013 | CN103070981A Traditional Chinese medicine composition for treating diabetic eye disease and preparation method thereof |
| 05/01/2013 | CN103070978A Preparation method of traditional Chinese medicine used for treating retinitis pigmentosa |
| 05/01/2013 | CN103070952A Preparation method of traditional Chinese medicine used for treating vernal conjunctivitis |
| 05/01/2013 | CN103070948A Pharmaceutical composition for treating eye diseases and preparation method |
| 05/01/2013 | CN103070947A Medicine for curing giddiness and preparation method thereof |
| 05/01/2013 | CN103070922A Drug for curing pinkeye |
| 05/01/2013 | CN103070899A Method for separating and purifying total flavone of dandelion |
| 05/01/2013 | CN103070877A Vision care drug |
| 05/01/2013 | CN103070868A IDO inhibitor containing NH-1,2,3-triazole and preparation method thereof |
| 05/01/2013 | CN102429862B Sustained-release povidone iodine eye drops |
| 05/01/2013 | CN102335412B Health-care product for otitis media |
| 05/01/2013 | CN102309519B Production method of calamine powder |
| 05/01/2013 | CN102302514B Pig blood deproteinized extract gel and preparation method thereof |
| 05/01/2013 | CN101583367B Materials and methods for treating and managing angiogenesis-mediated diseases |
| 05/01/2013 | CN101300005B N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 04/30/2013 | US8431589 2,4-diaminopyrimidine derivatives |
| 04/30/2013 | US8431380 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 04/30/2013 | US8431124 Methods for treating a disease characterized by an excess of hyaluronan by administering a soluble hyaluronidase glycoprotein (sHASEGP) |
| 04/30/2013 | CA2599425C Substituted gamma lactams as therapeutic agents |
| 04/30/2013 | CA2452491C Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 04/25/2013 | WO2013058579A1 Sirt 1 activator including syringaresinol |
| 04/25/2013 | WO2013058303A1 Medicinal composition |
| 04/25/2013 | WO2013058258A1 Bicyclic heterocyclic compound |
| 04/25/2013 | WO2013057183A1 Compositions for controlling vascularization in ophthalmological and dermatological diseases |